An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

[print friendlyprint friendly]

Recent postings to
Worst Pills, Best Pills Newsletter Articles

  View the entire July 2015 issue in PDF format

  • Public Citizen Shines a Light on Off-Label Promotion of Diabetes Drugs
    (July 2015)
    In a recent complaint to the FDA, we took several makers of diabetes drugs to task for direct-to-consumer ads that promote the drugs for unapproved uses. Find out the names of the drugs targeted in our complaint and the nature of the off-label uses being promoted in the ads.
  • New Study Reveals Many Patients at Risk for Dangerous Alcohol-Drug Interactions
    (July 2015)
    Recent research revealed that many patients consume alcohol while using drugs that may can cause dangerous side effects when combined with alcohol. Read this article to learn about the many ways alcohol can adversely interact with prescription and over-the-counter medications.
  • Industry Lawsuit Threatens FDA's Regulation of Drugs
    (July 2015)
    Worst Pills, Best Pills News editor Dr. Michael Carome discusses an unusual lawsuit filed by a drug company against the FDA that seeks to bypass the agency’s drug approval process and the prohibition against off-label promotion.
  • Eight Treatments Commonly Used for Osteoarthritis Pain
    (July 2015)
    Patients with osteoarthritis have many treatment options. Find out which ones are safest for relieving osteoarthritis pain.
  • News Brief for July 2015
    (July 2015)
    In this month’s news brief, we discuss Public Citizen’s recent petition to the FDA calling for a ban on all oral forms of a commonly used antifungal drug.

  View the entire June 2015 issue in PDF format

  • Risk of Sudden Death With Some Hypertension Drug-Antibiotic Combinations
    (June 2015)
    Find out which commonly used antibiotic can increase your risk of sudden death if it is combined with either an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB), which are among the most widely prescribed drugs in the U.S.
  • More Evidence of Dietary Supplements’ Dangers, Lack of Quality
    (June 2015)
    Worst Pills, Best Pills News editor Dr. Michael Carome discusses three recent events that reinforce the importance of being wary when considering the use of dietary supplements.
  • News Briefs for June 2015
    (June 2015)
    In our news briefs this month, we report on a recent FDA warning about the dangers of relying on over-the-counter homeopathic products to treat asthma. We also discuss the FDA’s very first approval of a biosimilar, which is essentially a generic version of a biologic drug.
  • More Dietary Potassium Can Reduce Occurrence of Hypertension, Amount of Drugs Needed for Its Treatment
    (June 2015)
    Learn why increasing the amount of potassium in your diet can help lower your blood pressure and reduce your risk of suffering a stroke. To help readers assess their potassium intake, we offer a list of potassium-rich foods.
  • Canada Issues Warnings on Alzheimer’s Disease Drugs
    (June 2015)
    Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration, recently warned physicians and patients about safety concerns regarding two drugs commonly used to treat Alzheimer’s disease. Find out the names of these drugs and the newly identified serious adverse events linked to them.
  • Injections for Age-Related Macular Degeneration
    (June 2015)
    Age-related macular degeneration is a leading cause of blindness and serious decreases in vision among patients age 50 and older. In this article, we provide our independent expert assessment of the available drug treatments for this disorder.

  View the entire May 2015 issue in PDF format

  • A Guide to Treatments for Osteoporosis
    (May 2015)
    Drug treatment can prevent broken bones in some women with osteoporosis. But drugs are not always necessary and can cause harmful side effects, especially when treatment lasts longer than needed. Read this article to learn who should take osteoporosis drugs, which drugs to take and for how long.
  • FDA Belatedly Requires Warnings About Heart Attack, Stroke Risks for Testosterone Products
    (May 2015)
    On March 3, the Food and Drug Administration finally announced that it was requiring that the labels of all approved prescription testosterone products include a warning about the possible increased risk of heart attacks and strokes. Worst Pills, Best Pills News editor Dr. Michael Carome criticizes the agency for recklessly dragging its feet prior to requiring these warnings.
  • Painkiller Tramadol Increases Risk of Low Blood Sugar
    (May 2015)
    For years, Public Citizen’s Health Research Group has designated tramadol as a Do Not Use drug. We discuss results of a new study providing an additional reason for avoiding tramadol: The drug has been linked to the occurrence of dangerously low blood sugar.
  • Falls in Elderly People: The Role of Blood Pressure Drugs
    (May 2015)
    Recent studies have confirmed that a significant cause of falls in the elderly is medication (and often overmedication) with drugs for high blood pressure, resulting in blood pressures low enough to increase the risk of falling — with attendant fractures and head injuries. Learn who is most at risk and what the blood pressure goal should be for patients age 60 or older.
  • Studies Cast Doubt on the Benefits of Raising HDL (‘Good’) Cholesterol
    (May 2015)
    This article discusses evidence from recent research that calls into question the benefits of taking drugs, such as niacin, to raise blood levels of high-density lipoprotein (HDL), often called “good” cholesterol.

   View back issues January 2004 - present

Additional Information from Public Citizen
Copyright © 2015 Public Citizen's Health Research Group. All rights reserved.